Mounjaro leads South Africa’s $187 million weight-loss drug boom as Aspen prepares Ozempic rival

South Africa’s market for popular diabetes and weight-management medicines has grown to almost $187 million (R3 billion), with Mounjaro leading sales as Aspen Pharmacare prepares a generic alternative to medicines such as Ozempic.